ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1788
-0,05%
Bitcoin
99.589,64
1,30%
Brent Oil
76,055
-0,59%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) Notícias

TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TWST
DataHoraFonteTítuloCódigoCompanhia
03/01/202517:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
26/12/202418:52Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TWSTTwist Bioscience Corporation
26/12/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
19/12/202410:00Business WireTwist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TWSTTwist Bioscience Corporation
18/11/202418:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TWSTTwist Bioscience Corporation
18/11/202418:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TWSTTwist Bioscience Corporation
18/11/202409:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWSTTwist Bioscience Corporation
18/11/202409:15Business WireTwist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
15/11/202418:05Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TWSTTwist Bioscience Corporation
14/11/202410:00Business WireTwist Bioscience to Present at 7th Annual Evercore HealthCONx ConferenceNASDAQ:TWSTTwist Bioscience Corporation
07/11/202418:05Business WireTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
31/10/202409:00GlobeNewswire Inc.Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AINASDAQ:TWSTTwist Bioscience Corporation
30/10/202409:00Business WireTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsNASDAQ:TWSTTwist Bioscience Corporation
24/10/202409:00Business WireTwist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024NASDAQ:TWSTTwist Bioscience Corporation
22/10/202409:00Business WireTwist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in CashNASDAQ:TWSTTwist Bioscience Corporation
15/10/202409:00Business WireTwist Bioscience Appoints Mike Fero, Ph.D., as Chief Information OfficerNASDAQ:TWSTTwist Bioscience Corporation
12/09/202409:00Business WireTwist Bioscience Achieves LEED Certification for Sustainable Operations and MaintenanceNASDAQ:TWSTTwist Bioscience Corporation
09/09/202409:00Business WireTwist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment PanelsNASDAQ:TWSTTwist Bioscience Corporation
27/08/202409:00Business WireTwist Bioscience to Present at Baird Global Healthcare Conference 2024NASDAQ:TWSTTwist Bioscience Corporation
08/08/202409:00Business WireTwist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kbNASDAQ:TWSTTwist Bioscience Corporation
05/08/202409:00Business WireTwist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for BiocatalysisNASDAQ:TWSTTwist Bioscience Corporation
02/08/202417:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TWSTTwist Bioscience Corporation
02/08/202408:30Business WireTwist Bioscience Reports Fiscal Third Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
18/07/202409:00Business WireTwist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody LibrariesNASDAQ:TWSTTwist Bioscience Corporation
11/07/202409:00Business WireTwist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
10/07/202409:00Business WireTwist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express AntibodiesNASDAQ:TWSTTwist Bioscience Corporation
09/07/202409:00Business WireTwist Bioscience Launches Synthetic RNA Control for H5N1 Influenza ANASDAQ:TWSTTwist Bioscience Corporation
06/06/202409:00Business WireTwist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint InhibitorNASDAQ:TWSTTwist Bioscience Corporation
04/06/202409:00Business WireTwist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI SafetyNASDAQ:TWSTTwist Bioscience Corporation
23/05/202409:00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:TWST

Seu Histórico Recente

BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
BEEF3
MINERVA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados